Adipocyte-derived factors suppress heart contraction

International Journal of Obesity

Volumn 35, Issue 1, 2011, Pages 84-90

  Look, C ^a   Morano, I ^b   Ehrhart Bornstein, M ^a   Bornstein, S R ^a   Lamounier Zepter, V ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

cardiodepressant activity; heart failure; metabolic syndrome

Indexed keywords

CYTOKINE; HEART MUSCLE DEPRESSANT FACTOR; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DATA ANALYSIS; FEMALE; HEART CONTRACTION; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE RELAXATION; HEART PERFUSION; HUMAN; HUMAN TISSUE; INCUBATION TEMPERATURE; ISOLATED HEART; MEDICAL RECORD; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; ADULT; AGED; ANIMALS; HEART; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; OBESITY; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 78651297514     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.121     Document Type: Article

References (35)

1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
2. Massie BM. Obesity and heart failureFrisk factor or mechanism? N Engl J Med 2002; 347: 358-359.
3. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004; 110: 3081-3087.
4. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313.
5. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991; 266: 231-236.
6. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000; 97: 1784-1789.
7. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001; 321: 225-236.
8. Hauner H. The new concept of adipose tissue function. Physiol Behav 2004; 83: 653-658.
9. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.
10. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738.
11. Lamounier-Zepter V, Ehrhart-Bornstein M, Karczewski P, Haase H, Bornstein SR, Morano I. Human adipocytes attenuate cardio-myocyte contraction: characterization of an adipocyte-derived negative inotropic activity. FASEB J 2006; 20: 1653-1659.
12. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A et al. Human adipocytes secrete mineralocorticoid- releasing factors. Proc Natl Acad Sci USA 2003; 100: 14211-14216.
13. Haase H, Dobbernack G, Tunnemann G, Karczewski P, Cardoso C, Petzhold D et al. Minigenes encoding N-terminal domains of human cardiac myosin light chain-1 improve heart function of transgenic rats. FASEB J 2006; 20: 865-873.
14. Qiu Y, Quilley J. Vascular effects of arachidonic acid in the rat perfused heart. Role of the endothelium, cyclooxygenase, cytochrome P450, and K(+) channels. J Lipid Res 1999; 40: 2177-2184.
15. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183: 949-958.
16. Nickola MW, Wold LE, Colligan PB, Wang GJ, Samson WK, Ren J. Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension 2000; 36: 501-505.
17. Sharma V, McNeill JH. The emerging roles of leptin and ghrelin in cardiovascular physiology and pathophysiology. Curr Vasc Pharmacol 2005; 3: 169-180.
18. Holycross BJ, Radin MJ. Cytokines in heart failure: potential interactions with angiotensin II and leptin. Mol Interv 2002; 2: 424-427.
19. Dixon RA, Davidson SM, Wynne AM, Yellon DM, Smith CC. The cardioprotective actions of leptin are lost in the Zucker obese (fa/fa) rat. J Cardiovasc Pharmacol 2009; 53: 311-317.
20. Smith CC, Mocanu MM, Davidson SM, Wynne AM, Simpkin JC, Yellon DM. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol 2006; 149: 5-13.
21. Ybarra J, Resmini E, Planas F, Navarro-Lopez F, Webb S, Pou JM et al. Relationship between adiponectin and left atrium size in uncomplicated obese patients: adiponectin, a link between fat and heart. Obes Surg 2009; 19: 1324-1332.
22. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004; 10: 1384-1389.
23. Kim M, Oh JK, Sakata S, Liang I, Park W, Hajjar RJ et al. Role of resistin in cardiac contractility and hypertrophy. J Mol Cell Cardiol 2008; 45: 270-280.
24. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 2002; 10: 1-5.
25. Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002; 91: 434-440.
26. Berry MF, Pirolli TJ, Jayasankar V, Burdick J, Morine KJ, Gardner TJ et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 2004; 110: II187-II193.
27. Kleinz MJ, Baxter GF. Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regul Pept 2008; 146: 271-277.
28. Lamounier-Zepter V, Look C, Alvarez J, Christ T, Ravens U, Schunck WH et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 2009; 105: 326-334.
29. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J 2007; 153: 907-917.
30. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-2466.
31. Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes 2008; 32: 268-274.
32. Iacobellis G, di Gioia CR, Di VM, Petramala L, Cotesta D, De S et al. Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. Horm Metab Res 2009; 41: 855-860.
33. Iacobellis G, di Gioia CR, Cotesta D, Petramala L, Travaglini C, De S et al. Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels. Horm Metab Res 2009; 41: 227-231.
34. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471-1477.
35. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prosta-cyclin. Pharmacol Rev 1978; 30: 293-331.